Subgroup Identification Based on Quantitative Objectives.

Area of Science:

• Biostatistics
• Pharmacogenomics
• Computational Biology

Background:

• Precision medicine aims to tailor treatments to individual patients, but identifying relevant subgroups is challenging.
• Subgroup identification is crucial for optimizing drug development and treatment efficacy.

Purpose of the Study:

• To introduce squant, a novel end-to-end computational solution for subgroup identification in drug development.
• To provide a flexible and interpretable method for discovering patient subgroups that respond differently to treatments.

Main Methods:

• The squant method transforms studies into artificial 1:1 randomized trials.
• It employs a flexible objective function and ensures a stable, interpretable signature.
• False discovery rate (FDR) control is embedded within the methodology.

Main Results:

• Simulations demonstrate the robust performance of the squant approach.
• The method successfully identified relevant subgroups in a real-world data example.
• The generated signatures were both stable and interpretable.

Conclusions:

• squant offers a powerful and practical tool for subgroup identification in precision medicine.
• The method facilitates more effective drug development by uncovering treatment-specific patient subgroups.
• The interpretability and FDR control enhance the clinical utility of the identified signatures.